Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions

Y Jamilloux, T Henry, A Belot, S Viel, M Fauter… - Autoimmunity …, 2020 - Elsevier
The coronavirus disease-19 pandemic (COVID-19), which appeared in China in December
2019 and rapidly spread throughout the world, has forced clinicians and scientists to take up …

The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from …

W Zhang, Y Zhao, F Zhang, Q Wang, T Li, Z Liu… - Clinical …, 2020 - Elsevier
The pandemic outbreak of coronavirus disease 2019 (COVID-19) is rapidly spreading all
over the world. Reports from China showed that about 20% of patients developed severe …

Structure-based virtual screening and molecular dynamics simulation of SARS-CoV-2 Guanine-N7 methyltransferase (nsp14) for identifying antiviral inhibitors against …

C Selvaraj, DC Dinesh, U Panwar… - Journal of …, 2021 - Taylor & Francis
The recent pandemic caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-
CoV-2) calls the whole world into a medical emergency. For tackling Coronavirus Disease …

Potential role of flavivirus NS2B-NS3 proteases in viral pathogenesis and anti-flavivirus drug discovery employing animal cells and models: a review

A Wahaab, BE Mustafa, M Hameed, NJ Stevenson… - Viruses, 2021 - mdpi.com
Flaviviruses are known to cause a variety of diseases in humans in different parts of the
world. There are very limited numbers of antivirals to combat flavivirus infection, and …

Viral proteases: Structure, mechanism and inhibition

J Zephyr, NK Yilmaz, CA Schiffer - The enzymes, 2021 - Elsevier
Viral proteases are diverse in structure, oligomeric state, catalytic mechanism, and substrate
specificity. This chapter focuses on proteases from viruses that are relevant to human health …

Inhibitors of the Zika virus protease NS2B-NS3

S Voss, C Nitsche - Bioorganic & medicinal chemistry letters, 2020 - Elsevier
In recent years, the Zika virus has emerged from a neglected flavivirus to a health-
threatening pathogen that causes epidemic outbreaks associated with neurological …

Benefits and adverse effects of hydroxychloroquine, methotrexate and colchicine: searching for repurposable drug candidates

DP Misra, AY Gasparyan, O Zimba - Rheumatology international, 2020 - Springer
Repurposing of antirheumatic drugs has garnered global attention. The aim of this article is
to overview available evidence on the use of widely used antirheumatic drugs …

[HTML][HTML] Clinical evidence for repurposing chloroquine and hydroxychloroquine as antiviral agents: a systematic review

C Rodrigo, SD Fernando, S Rajapakse - Clinical Microbiology and Infection, 2020 - Elsevier
Background Repurposing hydroxychloroquine (HCQ) and chloroquine (CQ) as antiviral
agents is a re-emerging topic with the advent of new viral epidemics. Aims To summarize …

Cytokine storm and colchicine potential role in fighting SARS-CoV-2 pneumonia

A Vitiello, F Ferrara, C Pelliccia, G Granata… - Italian Journal of …, 2020 - italjmed.org
For some patients with SARS-CoV-2, the worst clinical damage is not caused by the virus
itself, but by an overactive inflammatory state. In fact, in some people the immune system …

Drugs that offer the potential to reduce hospitalization and mortality from SARS-CoV-2 infection: The possible role of the sigma-1 receptor and autophagy

JM Brimson, MI Prasanth, DS Malar… - Expert Opinion on …, 2021 - Taylor & Francis
Introduction: Despite the availability of new vaccines for SARS-CoV-2, there has been slow
uptake and problems with supply in some parts of the world. Hence, there is still a necessity …